Status:
COMPLETED
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
Lead Sponsor:
Boston Children's Hospital
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6-35 years
Phase:
NA
Brief Summary
The aim of this study is to assess whether the 1 minute Sit to Stand (STS) test can be used as a measure of submaximal endurance during a pulmonary exacerbation of Cystic Fibrosis (CF) for patients in...
Eligibility Criteria
Inclusion
- patients age 6-35 with cystic fibrosis who are admitted for a pulmonary exacerbation and receive ongoing physical therapy throughout their admission.
Exclusion
- patients with cystic fibrosis who are under the age of 6,
- patients with cystic fibrosis who are not admitted for a pulmonary exacerbation,
- patients with cystic fibrosis who are not being followed regularly by physical therapy (\>5x/week) throughout their inpatient admission,
- patients with cystic fibrosis who are unable to follow instructions for standardized testing,
- patients with cystic fibrosis who are not medically stable to participate in submaximal exercise testing.
- patients whose inpatient admission is anticipated to be \<1 week.
- Patients who are readmitted to the hospital within the year will not be included in the study more than once.
Key Trial Info
Start Date :
September 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 12 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04058548
Start Date
September 5 2019
End Date
May 12 2021
Last Update
July 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115